Role of LncRNAs in vascular diseases

doi:10.3969/j.issn.1674-8115.2016.04.023

Abstract

Abstract:

Vascular diseases are a serious problem that threats human health with key pathological characteristics of aberrant proliferation of vascular smooth muscle cells and formation of neointimal lesions. Recent evidence has demonstrated that non-coding RNAs play an important role in the regulation of tissue homeostasis and pathophysiological conditions. Besides microRNAs (miRNAs), long non-coding RNAs (LncRNAs) contribute to gene expression and signaling pathway at various stages. Recently, LncRNAs have been identified to play a role in vascular development, lineage commitment, and mesoderm differentiation into heart and to be associated with angiotensin Ⅱ actions and vascular diseases, including heart diseases and atherosclerosis. LncRNAs may mediate many different pathways in vascular development and related diseases. This review mainly discusses the role of LncRNAs in vascular diseases.

Key words: long noncoding RNAs, vascular disease, vascular development

HUANG Chun-mei, WANG Xiao, GE Qin-min. Role of LncRNAs in vascular diseases[J]. , doi: 10.3969/j.issn.1674-8115.2016.04.023.

[1]	LI Ping, JIANG Huiru, YE Mengyue, WANG Yayu, CHEN Xiaoyu, YUAN Ancai, XU Wenjie, DAI Huimin, CHEN Xi, YAN Xiaoxiang, TU Shengxian, ZHENG Yuanqi, ZHANG Wei, PU Jun. Analysis of epidemiological characteristics of risk factors for cardiovascular diseases and malignant tumors based on the Shanghai community elderly cohort [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2024, 44(5): 617-625.
[2]	ZHAO Qian, WANG Ying, HAMULATI Xieyire, TUERXUN Gulijiehere, LI Xiaomei, YANG Yining. Correlation analysis between sleep quality and carotid atherosclerosis in low and moderate risk individuals for cardiovascular and cerebrovascular diseases [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2023, 43(11): 1366-1373.
[3]	Xieyire·HAMULATI , ZHAO Qian, LI Cheng, SONG Ning, WANG Ying, Gulijiehere·TUERXUN , PU Jun, YANG Yining, LI Xiaomei. Clinical characteristics and health economics evaluation of real-world-based ischemic cardiovascular and cerebrovascular co-morbidities [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2022, 42(6): 778-785.
[4]	LI Guodong, YAN Shaohua, ZHANG Qiuxia, LEI Li, ZHANG Xinlu, LIANG Hongbin, LU Junyan, XIAO Min, LUO Wei, PU Jun, XIU Jiancheng. Evaluation of the application effect of “Internet+”-based “co-prevention and co-management” health management model for cardio-cerebrovascular diseases on the improvement of blood pressure in target surveillance population in community [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2022, 42(6): 797-804.
[5]	HE Zhijie, HE Jinchun, ZHANG Yanpei, WANG Yaodong, WANG Zhanke. Analysis of lipoprotein subclasses of family with familial hypertriglyceridemia based on VAP method [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2022, 42(4): 482-489.
[6]	ZHANG Mengji, HUANG Lin, LI Zheng, MA Zhuoran, WEI Lin, YUAN Ancai, HU Liuhua, ZHANG Wei, QIAN Kun, PU Jun. Plasma metabolic signature of cardiovascular and cerebrovascular diseases from a large cohort study [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2022, 42(3): 259-266.
[7]	ZHANG Tong, TIAN Xue, ZUO Yingting, ZHENG Manqi, ZHANG Yijun, WU Shouling, CHEN Shuohua, MA Gaoting, TONG Xu, WANG Anxin, MO Dapeng. Association of triglyceride-glucose index with cardiovascular disease in people without traditional risk factors [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2022, 42(3): 267-274.
[8]	Ming-qi CAI, Yan CHEN, Kai-bin LIN, Dong HUANG. Advances in the role of growth differentiation factor 11 in cardiovascular diseases [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(6): 834-838.
[9]	Shu-jun WAN, Xiang KONG, Kun LÜ. Relationship between non-coding RNAs and vascular diseases of diabetes mellitus [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(5): 665-670.
[10]	Min SUN, Dong-ying ZHANG. Progress of cardioprotection effect of sodium-glucose cotransporter 2 inhibitor on patients with type 2 diabetes [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(3): 391-395.
[11]	Hua-jie DAI, Li-ping XUAN, Jia-li XIANG, Hong LIN, Zhi-yun ZHAO, Tian-ge WANG, Mian LI, Yu XU, Jie-li LU, Wei-qing WANG, Yu-fang BI, Min XU. Correlation between healthy vascular aging and prevalent cardiovascular disease risk in middle-aged and elderly people in the community of Shanghai [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(2): 223-227.
[12]	LU Yan-qiao, SHEN Lan, HE Ben. Application of artificial intelligence in assisted diagnosis and treatment of cardiovascular disease [J]. , 2020, 40(2): 259-.
[13]	XU Yu-peng1, DU Yu-chen1, 2, CHEN Feng-e1. Automatic layer segmentation of optical coherence tomography images in retinal vascular diseases [J]. , 2019, 39(6): 613-.
[14]	JI Hai-ying, YOU Sha-sha, CAO Hui-min, HE Bin. Clinical research of PCSK9 inhibitors in reducing low density lipoprotein cholesterol [J]. , 2018, 38(2): 212-.
[15]	ZHAO Dan-dan, GU Yan-yun, WANG Ji-qiu, HU Chun-xiu, HONG Jie, ZHANG Yi-fei, the SPREAD-DIMCAD study group. Study on the predictive effect of baseline lipid profiles on recurrent cardiovascular events after antidiabetic drugs intervention [J]. , 2017, 37(6): 744-.

Role of LncRNAs in vascular diseases

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

TrendMD

References

Related Articles 15

Recommended Articles

Metrics

Comments